Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - A retrospective single-center analysis

Digestion

Volumn 68, Issue 2-3, 2003, Pages 94-101

  Kress, O ^a   Wagner, H J ^a   Wied, M ^a   Klose, K J ^a   Arnold, R ^a   Alfke, H ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Liver metastases; Neuroendocrine tumor; Transarterial chemoembolization

Indexed keywords

ALPHA INTERFERON; CONTRAST MEDIUM; DOXORUBICIN; GELFOAM; IODINATED POPPYSEED OIL; IOPAMIDOL; OCTREOTIDE; POLYVINYL ALCOHOL;

ADULT; AGED; ARTERY DISSECTION; ARTERY SPASM; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CARCINOID SYNDROME; CARDIOTOXICITY; CAUSE OF DEATH; CHEMOEMBOLIZATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOMA; HUMAN; HYPOTENSION; IDIOPATHIC DISEASE; INSULINOMA; INTESTINE TUMOR; LIVER FAILURE; LIVER METASTASIS; MALE; MORTALITY; NAUSEA AND VOMITING; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; STOMACH TUMOR;

ADULT; AGED; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DOXORUBICIN; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0346727160     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074522     Document Type: Article

References (20)

1. Kloppel G, Heitz PU: Classification of normal and neoplastic neuroendocrine cells. Ann NY Acad Sci 1994;733:19-23.
2. Moertel CG: Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1502-1522.
3. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS: Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108:1091-1096.
4. Godwin JD 2nd: Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975;36:560-569.
5. Therasse E, Breittmayer F, Roche A, De Baere T, Indushekar S, Ducreux M, Lasser P, Elias D, Rougier P: Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993;189:541-547.
6. Perry LJ, Stuart K, Stokes KR, Clouse ME: Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 1994; 116:1111-1117.
7. Clouse ME, Perry L, Stuart K, Stokes KR: Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 1994; 55(suppl 3):92-97.
8. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S, Ychou M, Mignon M: Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993;71:2624-2630.
9. Hartnell GG, Gates J, Stuart K, Underhill J, Brophy DP: Hepatic chemoembolization: Effect of intraarterial lidocaine on pain and post-procedure recovery. Cardiovasc Intervent Radiol 1999;22:293-297.
10. Cascade PN, Kastan DJ: Monitoring and evaluating the quality and appropriateness of angiographic/interventional radiologic procedures. Radiology 1990;174:926-928.
11. Carrasco CH, Charnsangavej C, Ajani J, Samaan NA, Richli W, Wallace S: The carcinoid syndrome: Palliation by hepatic artery embolization. AJR Am J Roentgenol 1986;147:149-154.
12. Moertel CG, Johnson CM, McKusick MA, Martin JK Jr, Nagorney DM, Kvols LK, Rubin J, Kunselman S: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120:302-309.
13. Engstrom PF, Lavin PT, Moertel CG, Folsch E, Douglass HO Jr: Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 1984;2:1255-1259.
14. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D: Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992;326:519-523.
15. Roche A: Hepatic chemo-embolization. Bull Cancer 1989;76:1029-1037.
16. Kvols LK, Buck M, Moertel CG, Schutt AJ, Rubin J, O'Connell MJ, Hahn RG: Treatment of metastatic islet cell carcinoma with a soma-tostatin analogue (SMS 201-995). Ann Intern Med 1987;107:162-168.
17. Oberg K, Norheim I, Lind E, Alm G, Lundqvist G, Wide L, Jonsdottir B, Magnusson A, Wilander E: Treatment of malignant carcinoid tumors with human leukocyte interferon: Long-term results. Cancer Treat Rep 1986;70:1297-1304.
18. Saltz L, Trochanowski B, Buckley M, Heffernan B, Niedzwiecki D, Tao Y, Kelsen D: Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer 1993;72:244-248.
19. Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom AT: Long-term results of continuous treatment with recombinant interferon-α in patients with metastatic carcinoid tumors - An antiangiogenic effect? Anticancer Drugs 1996;7:175-178.
20. Mitty HA, Warner RR, Newman LH, Train JS, Parnes ICH: Control of carcinoid syndrome with hepatic artery embolization. Radiology 1985;155:623-626.